Equities
Basic MaterialsChemicals
  • Price (EUR)65.45
  • Today's Change0.600 / 0.93%
  • Shares traded332.52k
  • 1 Year change-17.67%
  • Beta1.2820
Data delayed at least 15 minutes, as of Feb 11 2026 16:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Arkema SA is a France-based chemical producer, which provides specialty chemicals and advanced materials. The Company manufactures a range of products for industries, including construction, packaging, chemical, automotive, electronics, food, and pharmaceutical industries. The Company operates through five business segments: Advanced materials that includes high performance polymers, specialty surfactants, molecular sieves, organic peroxides, oxygenates, and others; Adhesives that includes sealants, adhesives for floors and tiles, waterproofing products, and others; Coating solutions that include resins, emulsions for adhesives, surface coating products, absorbents, and others; Intermediate products that include thermoplastic polymers (PMMA) polymethyl methacrylate, acrylic products, fluorinated gases, and others. The Company has production centers located in Europe, North America and Asia. It operates through a network of subsidiaries, such as XL Brands.

  • Revenue in EUR (TTM)9.24bn
  • Net income in EUR127.00m
  • Incorporated2002
  • Employees21.15k
  • Location
    Arkema SA420 rue d'Estienne d'OrvesPUTEAUX 92800FranceFRA
  • Phone+33 149008080
  • Fax+33 149008396
  • Websitehttps://www.arkema.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
K+S AG3.64bn-1.70bn2.62bn11.36k--0.6142--0.7193-9.49-9.4920.3223.800.44334.575.44317,413.70-20.704.08-22.484.8211.9221.93-46.7010.052.33--0.103919.65-5.677.46-131.82--0.632430.26
Solvay SA4.91bn154.00m2.96bn8.67k19.332.436.010.6041.451.4546.4011.520.76286.546.77565,809.202.522.593.433.4021.2424.793.304.201.048.610.635978.01-14.84-14.50270.23---19.76-8.31
Clariant AG4.45bn123.68m3.07bn10.27k24.711.457.030.69080.34210.342112.305.820.66763.786.73388,246.502.432.493.373.6131.8029.563.643.710.89936.670.496283.72-5.14-1.1545.24---6.28-32.51
Kemira Oyj2.81bn219.10m3.22bn4.77k15.151.907.511.141.411.4118.1511.290.8736--6.56598,914.407.205.969.437.98--37.458.246.441.2815.370.284753.39-12.872.0925.2617.75-3.615.73
Gubre Fabrikalari TAS1.02bn116.14m3.34bn1.89k28.806.3222.293.2918.0417.70158.1082.261.015.989.2429,228,970.0011.850.431622.301.1722.8414.1911.680.3220.8961--0.2032---4.7261.98137.70--76.38--
Wacker Chemie AG5.57bn21.70m4.11bn16.62k178.330.91627.420.73780.44160.4416112.1785.950.63612.866.74334,573.500.43087.020.51758.7015.2821.690.67739.281.642.840.304648.76-10.633.03-23.15--9.4437.97
SOL SpA1.70bn156.30m4.28bn7.41k27.374.0413.072.511.721.7218.7911.680.78963.993.36233,844.907.627.889.7710.1874.3672.789.649.862.0413.820.414222.168.2912.231.3524.528.5017.38
Johnson Matthey PLC13.07bn-145.66m4.51bn10.64k--1.8798.230.3448-0.7474-0.759367.3812.501.9010.547.751,070,556.00-2.123.05-3.565.417.046.81-1.111.491.286.020.415365.12-9.10-4.34245.377.90-3.386.72
Umicore SA16.10bn128.82m4.77bn11.41k36.062.2810.930.29640.53720.537267.068.501.916.3812.701,390,302.001.720.39842.990.66667.766.540.8970.17550.72472.340.5876273.74-18.68-3.21-484.31---0.19165.92
Arkema SA9.24bn127.00m4.93bn21.15k38.820.67595.270.53411.671.67122.0095.950.6385.566.80438,098.800.9675.291.146.3618.6821.181.527.062.264.380.364536.030.31531.78-15.92-7.202.8610.35
Croda International Plc1.91bn160.46m5.13bn6.03k31.992.0215.972.681.001.0011.9315.870.47362.454.59276,754.604.049.314.5710.6345.1046.268.5417.371.199.910.248547.86-3.923.40-7.31-6.6810.374.10
Imcd NV4.82bn266.69m5.63bn5.28k20.812.8513.851.174.584.5882.6533.461.065.345.26939,651.805.857.007.899.4022.4821.915.546.061.044.720.467144.626.4111.94-4.8020.848.3419.03
Evonik Industries AG14.27bn94.00m7.39bn31.30k79.860.88475.960.51770.19850.200630.8517.920.74874.248.68446,789.800.5721.530.71611.8622.5625.060.7642.120.79786.760.3481176.60-0.72052.95147.74-21.67-0.92610.3454
Data as of Feb 11 2026. Currency figures normalised to Arkema SA's reporting currency: Euro EUR

Institutional shareholders

26.07%Per cent of shares held by top holders
HolderShares% Held
ISALT-Investissements Strat�giques en Actions Long Terme SASUas of 31 Dec 20245.95m7.82%
Norges Bank Investment Managementas of 26 Nov 20243.76m4.95%
The Vanguard Group, Inc.as of 07 Jan 20262.21m2.91%
Dimensional Fund Advisors LPas of 08 Jan 20261.38m1.82%
Wellington Management Co. LLPas of 05 Feb 20261.15m1.51%
FIL Investments Internationalas of 09 Jan 20261.12m1.47%
Amundi Austria GmbHas of 31 Dec 20251.12m1.47%
M&G Investment Management Ltd.as of 31 Oct 20251.08m1.42%
JPMorgan Asset Management (UK) Ltd.as of 31 Dec 20251.07m1.41%
Fidelity Investments Canada ULCas of 30 Nov 2025994.07k1.31%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.